Publications by authors named "B K Piao"

Objectives: Glycoprotein (GP) IIb/IIIa receptor antagonists (Tirofiban) are often used as antiplatelet agents in patients undergoing interventional therapy due to acute coronary syndrome and cerebrovascular diseases. Thrombocytopenia is a common complication of GP IIb/IIIa receptor antagonist, with an incidence of 1%-5%, whereas acute profound thrombocytopenia (platelet count<20 × 109/L) is extremely rare. We reported a case of acute profound thrombocytopenia due to tirofiban treatment to inhibit platelet aggregation during and after surgery in a patient who underwent stent-assisted embolization for ruptured intracranial aneurysm.

View Article and Find Full Text PDF

Cancer stem cells (CSCs) are small subpopulations of neoplastic cells within a tumor, which have self-renewal and differentiation abilities and could generate new tumors with few cells. Researches have showed that CSCs are considered the most likely reason for cancer recurrence and metastasis. Accumulating evidences have showed that traditional Chinese medicine (TCM) has significant effect on CSCs.

View Article and Find Full Text PDF

Mucins (MUC) constitute an important component of the inflammatory and innate immune response. However, the expression of these molecules by respiratory viral infections is still largely unknown. Respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) are two close-related paramyxoviruses that can cause severe low respiratory tract disease in infants and young children worldwide.

View Article and Find Full Text PDF

Objective: To explore the possible immuno-regulating mechanism of action of Chinese drugs in different combinations (assembled depending different therapeutic principles) through observing the effects of Feiliuping ointment (FLP) and its disassembled prescriptions on dendritic cells (DC) in blood, spleen and tumor in mice with transplanted Lewis lung cancer (LLC).

Methods: Percentages of DC in blood, spleen and tumor of mice with transplanted LLC treated by FLP and its disassembled prescriptions were estimated, and the S-100 protein expression in tumor tissue was detected by immunohistochemical method.

Results: The percentage of DC (per thousand) in tumor bearing mice was 0.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer stem cells (CSCs) are crucial in cancer development and resistance to treatment, and oxymatrine is being studied for its potential to target these cells.
  • Oxymatrine was tested on MCF-7 breast cancer cells, focusing on its ability to reduce cell proliferation and specifically target cancer stem-like cells.
  • The results suggest that oxymatrine’s effectiveness may involve inhibiting the Wnt/β-catenin signaling pathway, indicating it could be an innovative therapeutic option against breast cancer CSCs.
View Article and Find Full Text PDF